Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery
Crossref DOI link: https://doi.org/10.1245/s10434-023-13266-0
Published Online: 2023-03-19
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Akimoto, Eigo
Kuwata, Takeshi
Shitara, Kohei
Kawazoe, Akihito
Sakamoto, Naoya
Ishii, Genichiro
Ochiai, Atsushi
Kinoshita, Takahiro
Text and Data Mining valid from 2023-03-19
Version of Record valid from 2023-03-19
Article History
Received: 1 November 2022
Accepted: 3 January 2023
First Online: 19 March 2023